RxDoctor Payments Data

James Clarkson, MD

Medical Oncology · Pascagoula, MSNPI 1285711978

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 93 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 10.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,278 and has fallen 97.4% since, to $34 in 2024. That places this record below the midpoint for medical oncology clinicians in MS, where the typical reported total is $7,285.

$2,171in general payments, 2019–2025

Across 93 payments — averaging $23.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$235
  • Incyte Corporation$187
  • Bristol Myers Squibb$162
  • E.r. Squibb & Sons, L.L.C.$152
  • Ipsen Biopharmaceuticals, Inc$146
  • Amgen$138
  • plus $1K from 27 others
$2,013in research payments, 2019–2025

Across 2 payments — averaging $1006.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Amgen$2K

What the payments were for

  • Food & beverage$2,171100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,171 in reported general payments places this provider in the 15th percentile of 20 medical oncology providers in Mississippi.

See all medical oncology providers in Mississippi

Medicare billing

Part B allowed, 2024
$10,947
Medicare patients
54
Services billed
144

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydroxyurea14$218
Alendronate Sodium12$31

Paid to pharmacies, not to this prescriber.

Other medical oncology in Pascagoula

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →